In a perfect democracy, at least 50% of people would support every decision.

The U.S. falls short of this goal.

Activate to continue

Spoken For.
House vote: H.R. 5651 // May 30, 2012Needed two-thirds to pass

Food and Drug Administration Reform Act of 2012

Sponsor: FRED UPTON (R-MI)

Food and Drug Administration Reform Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to reauthorize and establish new Food and Drug Administration (FDA) prescription drug user-fee programs and to revise and impose new requirements relating to: (1) prescription, pediatric, and generic drugs; (2) medical devices; (3) biosimilar biological products; and (4) registration of drug manufacturers and reporting of drug shortages. Title I: Fees Relating to Drugs - Prescription Drug User Fee Amendments of 2012 - (Sec. 103) Extends through FY2017 the authority of the Secretary of Health and Human Services (HHS) to assess and collect human drug application and supplement fees, prescription drug establishment fees, and prescription drug product fees to support the FDA drug development process and the process for the review of human drug applications. Increases for FY2013-FY2017 the level of required prescription drug user fee revenues.

Health Topic assigned by the Congressional Research Service.

Who won, and how much of the country was behind them

Won the vote · Yea

377 votes, representing 208,324,399 people86.9%of U.S. adults

Lost the vote · Nay

5 votes, representing 2,772,349 people1.2%of U.S. adults

The dotted gap is 11.9% of U.S. adults whose member did not vote, voted “present,” or whose seat was vacant.

Share of U.S. adults represented, the House
SideOutcomeVotesShare of U.S. adults
YeaWon37786.9%
NayLost51.2%
Not represented on this questionNo position taken011.9%